KIRSCH ARTHUR S — SEC insider filings
SEC reporting owner CIK 1290976. 20 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2021-03-26 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 40,000 shares, $260,200 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 30,000 shares, $1,731,300 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 15,000 shares @ $60.22 ($903,300) in Liquidia Corp, filed 2026-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Liquidia Corp (LQDA) | Director | 11 | 1 leg · 30,000 sh · $127,200 | 3 legs · 30,000 sh · $1,731,300 | 9 |
| Evommune, Inc. (EVMN) | Director | 4 | 1 leg · 10,000 sh · $133,000 | — | 6 |
| Kadmon Holdings, Inc. (KDMN) | Director | 3 | — | — | 8 |
| Atea Pharmaceuticals, Inc. (AVIR) | Director | 2 | — | — | 3 |
Insider filings — KIRSCH ARTHUR S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Liquidia Corp (LQDA) | Option exercise (M): 8,914 @ $20.36 · Option exercise (M): 8,914 (derivative) @ $0 | EDGAR |
| 2026-11-17 | 4 | Evommune, Inc. (EVMN) | Disposition to issuer (D): 37,960 (derivative) · Grant/award (A): 37,960 (derivative) · Disposition to issuer (D): 15,673 (derivative) · Grant/award (A): 15,673 (derivative) | EDGAR |
| 2026-07-08 | 4 | Evommune, Inc. (EVMN) | Purchase (P): 10,000 @ $13.30 | EDGAR |
| 2026-06-23 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 5,882 @ $0 | EDGAR |
| 2026-06-03 | 4 | Liquidia Corp (LQDA) | Sale (S): 15,000 @ $60.22 · Sale (S): 5,000 @ $56 · Sale (S): 10,000 @ $54.80 | EDGAR |
| 2026-06-03 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 15,673 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Evommune, Inc. (EVMN) | Grant/award (A): 37,960 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 18,396 @ $0 | EDGAR |
| 2025-02-24 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 164,800 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 20,359 @ $0 | EDGAR |
| 2023-11-22 | 4 | Liquidia Corp (LQDA) | Holdings only — no transactions reported | EDGAR |
| 2023-06-21 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-11-12 | 4 | Liquidia Corp (LQDA) | Purchase (P): 30,000 @ $4.24 | EDGAR |
| 2021-11-09 | 4 | Kadmon Holdings, Inc. (KDMN) | Disposition to issuer (D): 30,000 @ $9.50 · Disposition to issuer (D): 64,103 (derivative) @ $7.21 · Disposition to issuer (D): 100,000 (derivative) @ $7.21 · Disposition to issuer (D): 85,034 (derivative) @ $5.06 · Disposition to issuer (D): 96,975 (derivative) @ $5.92 | EDGAR |
| 2021-09-01 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4 | Kadmon Holdings, Inc. (KDMN) | Grant/award (A): 20,000 @ $3.58 · Grant/award (A): 10,000 @ $3.69 | EDGAR |
| 2021-05-13 | 4 | Kadmon Holdings, Inc. (KDMN) | Grant/award (A): 96,975 (derivative) @ $0 | EDGAR |
| 2021-03-26 | 4 | Liquidia Corp (LQDA) | Grant/award (A): 41,390 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1290976 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs